191 related articles for article (PubMed ID: 9668368)
21. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
22. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
Tang J; Yuan J; Hao H
Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.
Wirguin I; Suturkova-Milosevic L; Della-Latta P; Fisher T; Brown RH; Latov N
Ann Neurol; 1994 Jun; 35(6):698-703. PubMed ID: 8210226
[TBL] [Abstract][Full Text] [Related]
24. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
25. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
26. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
27. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
28. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
29. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
[TBL] [Abstract][Full Text] [Related]
30. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
31. IgM anti-GM1 antibodies in the Guillain-Barré syndrome: a serological predictor of the clinical course.
Bech E; Orntoft TF; Andersen LP; Skinhøj P; Jakobsen J
J Neuroimmunol; 1997 Jan; 72(1):59-66. PubMed ID: 9003245
[TBL] [Abstract][Full Text] [Related]
32. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter jejuni associated with Guillain-Barré syndrome.
Neisser A; Schwerer B; Bernheimer H; Moran AP
J Neuroimmunol; 2000 Jan; 102(1):85-8. PubMed ID: 10626671
[TBL] [Abstract][Full Text] [Related]
33. Guillain-Barré syndrome associated with IgM anti-GM1 antibody following Campylobacter jejuni enteritis.
Sugita K; Ishii M; Takanashi J; Niimi H; Yuki N
Eur J Pediatr; 1994 Mar; 153(3):181-3. PubMed ID: 8181502
[TBL] [Abstract][Full Text] [Related]
34. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
35. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome.
Jacobs BC; Hazenberg MP; van Doorn PA; Endtz HP; van der Meché FG
J Infect Dis; 1997 Mar; 175(3):729-33. PubMed ID: 9041356
[TBL] [Abstract][Full Text] [Related]
36. Acute immune polyneuropathies: correlations of serum antibodies to Campylobacter jejuni and Helicobacter pylori with anti-GM1 antibodies and clinical patterns of disease.
Nevo Y; Pestronk A
J Infect Dis; 1997 Dec; 176 Suppl 2():S154-6. PubMed ID: 9396701
[TBL] [Abstract][Full Text] [Related]
37. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
Koga M; Takahashi M; Yokoyama K; Kanda T
J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
[TBL] [Abstract][Full Text] [Related]
38. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
39. Human monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndrome.
Prendergast MM; Willison HJ; Moran AP
Infect Immun; 1999 Jul; 67(7):3698-701. PubMed ID: 10377164
[TBL] [Abstract][Full Text] [Related]
40. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a.
Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
Brain; 2000 Jan; 123 ( Pt 1)():116-24. PubMed ID: 10611126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]